On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune ...

As chief medical officer, Tom Purcell, MD, MBA, is overseeing an organization-wide initiative to improve the delivery of care ...

Screening is an effective tool for reducing the burden of cancer,” per Fred Hutch public health researcher Chris Li. “But it's a complex process with multiple steps." Unfortunately, many Americans are ...

Stuart and Molly Sloan add to their 2022 transformational gift to boost their impact on research and care SEATTLE – July 22, 2025 – A Fred Hutch Cancer Center outpatient complex serving more than ...

The Food Biomarkers Study (FBS) is a research project to help scientists learn how markers of consuming certain protein foods appear in blood and urine. The study involves three, 9-day study food ...

SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...

When Jacqueline Woodfork got sick, the ER physicians found a mass in her chest that turned out to be thymic carcinoma. Woodfork credits her illness — which turned out to be COVID — with saving her ...

It’s official — the Fred Hutch/University of Washington Cancer Consortium is now serving the entire Evergreen state. For years, the Cancer Consortium — composed of Fred Hutch, the University of ...

Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...